Obs & Gynae Flashcards
(635 cards)
how does oestrogen act in the follicular phase
- stimulate fallopian tube function
- thicken endometrium
- growth and motility of myometrium
- thin alkaline cervical mucus
- vaginal changes
how does progesterone act in the luteal phase
- acts on oestrogen-primed cells to cause further thickening of endometrium
- thickening of myometrium with reduced motility
- thick acidic cervical mucus
- changes in mammary tissue
describe the HPG axis at the beginning of the cycle
- follicles part-developed therefore very little steroid or inhibin production
- low inhibition at hypothal and pituitary therefore fsh and lh levels rise
- fsh binds to granulosa cells to stimulate development
- lh acts on theca interna cells to produce oestrogen
describe the HPG axis around the time of ovulation
- rising oestrogen levels causes hpg axis to swtich to positive - increase in oestrogen
- lh carries on rising
- fsh rises, but not to same extent due to inhibin production
- inhibin also means no new follicles can develop
- lh surge causes ovulation
describe the HPG axis at the end of the cycle
- after ovulation, corpus luteum forms,
- steroid levels rise - oestrogen + progesterone
- oestrogen suppresses fsh, progesterone suppresses lh
- fast drop in hormone and progesterone levels due to lack of fertilisation causes menses
what is the normal range for the ovarian cycle
24-32 days
list some of the common causes for menorrhagia
- abnormal clotting: VWF disease, thrombocytopenia, coag disorders, leukaemia etc
- pathology: fibroids, adenomyosis, endometriosis, polyps etc
- medical disorders: hypo/hyperthyroid, liver disease, sle, cancer
- DUB: primary menorrhagia - heavy bleeding with no recognisable pelvic pathology/bleeding disorder
list some of the factors affecting menstrual loss
- age: 4th decade
- hereditary
- parity
- uterina pathology
- cycle-cycle vaiability
list some of the ways to investigate menorrhagia
- FBC: Hb, platelets, clotting factors as necessary
- TFTs
- coagulation
- USS/TVUS
- hysteroscopy
- biopsy
- (colposcopy)
- (smear)
list some of the treatments for managing menorrhagia
- progestogens e.g. norethisterone, depot
- Mefenamic acid/ other NSAIDs
- tranexamic acid - antifibrinolytic
- IUCD - Mirena (progesterone-impregnated), not copper coil
- cocp
- surgical: endometrial ablation, cold coag treatment, laser; hysterectomy as last result
what is the mechanism of action of tranexamic acid
antifibrinolytic - inhibits plasminogen activation into plasmin. plasmin usually causes fibrin degradation - therefore TXA inhibits fibrin breakdown
what is PCOS
endocrine disorder of unknown aetiology, which can be hereditary.
accounts for majority of causes of amenorrhoea
what are the pathological features of PCOS
- ovarian hypersecretion of andorgens
- increased pulsatile secretion of LH
- ovarian theca cell hyperplasia leading to ovarian enlargement
- anovulation
- insulin resistance
what are the clinical features of PCOS
- oligo/amenorrhoea
- DUB
- obesity
- hirsuitism
- acne
- ‘string of pearls’ appearance of ovaries on USS
what are the biochemical features of PCOS
- increased LH:FSH ratio
- decreased sex hormone binding globulin
- increased free androgen index
- increased serum insulin
what are the differentials for PCOS
- anovulatory cycles
- congenital adrenal hyperplasia
- androgen secreting tumours
- cushings syndrome
what are the long-term health complications of PCOS
- miscarriage
- gestational diabetes
- NIDDM
- HTN
- cardiovasc disease
- endometrial hyperplasia/carcinoma
what is the management for PCOS
- weight loss
- metformin
- COCP
- cyproterone acetate (antiandrogen)
- ovulation induction in infertility
- ovarian drilling
- cyclical progestogen
what is the definition of menopause
permanent cessation of menstruation due to loss of ovarian follicular activity - 12 months since LMP
what is LMP
last menstrual period - calculated as the first day of the last period a woman has had
what are the symptoms of the menopause
- hot flushes and night sweats
- irritability, mood changes, lack of concentration, depression
- reduced libido
what is hrt for
oestrogen replacement therapy (combined with progestogens if uterus intact)
used to manage symptoms of menopause
list some of the risks associated with hrt
- effects of unapposed oestrogen: increased endometrial/ovarian/breast cancer risk
- increased IHD/stroke; adverse effect on lipid profile
- increased risk of vte; adverse effect on thrombophilia profile
what are the different modes of administration of hrt
- po
- transdermal
- implant
- transvaginal
- nasal
- local